Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Breakfast reveals hidden heart risks in those who skip healthy eating rules

NCT ID NCT01579409

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 94 adults to see if following French nutrition guidelines affects blood vessel health. Participants were split into two groups based on their diet quality, and researchers measured artery stiffness and blood flow before and after a standard breakfast. The goal was to understand how diet impacts heart and blood vessel function, even in people without known disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

94 people

The number who actually took part.

Started

Nov 2011

Finished

Mar 2014

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 to 75 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Social Security affiliation. * Participation in SU.VI.MAX 2. * Subjects without legal guardian who can freely agree to participate to the study. * PNNS score in 2012 lower (cases) or upper (controls) quartile. Exclusion Criteria: * Known diabetes or prediabetes before the inclusion. * History of cardiovascular disease. * Treatment for hypertension. * Treatment for dyslipidemia. * Known Cancer * Smoking or patients that have stopped smoking less than 3 years * Cardiac pacemaker

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for French PNNS guidelines in vascular function are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hôpital Jean Verdier Service d'Endocrinologie-Diabétologie-Nutrition Avenue du 14 juillet

    Bondy, 93149, France